Skip to main content
. 1998 Jan;111(1):48–55. doi: 10.1046/j.1365-2249.1998.00452.x

Fig. 3.

Fig. 3

Linear regression analysis of the correlations between anti-lipoarabinomannan (LAM) and anti-cell-free proteic extract (CFX) antibody levels in leprosy patients (a), and between anti-LAM and anti-38-kD antibodies in tuberculosis patients (b). Because of a high dispersion of figures, values > 160 000 and 40 000 ng/ml for anti-LAM in (a) and (b), respectively, 350 000 ng/ml for anti-CFX and 12 000 ng/ml for anti-38 kD are not represented.